FDA Approves Vyjuvek

FDA Approves Vyjuvek (beremagene geperpavec-svdt) Redosable Gene Therapy for the Treatment of Dystrophic Epidermolysis Bullosa PITTSBURGH, May 19, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the Company) (NASDAQ: KRYS), a […]

» Read more

FDA Approves Lumryz

FDA Approves Lumryz (sodium oxybate) for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy DUBLIN, May 01, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company […]

» Read more

FDA Approves Omisirge

FDA Approves Omisirge (omidubicel-onlv) Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation BOSTON–(BUSINESS WIRE)–Apr. 17, 2023– Gamida Cell Ltd. (Nasdaq: GMDA), a […]

» Read more
1 2 3 14